Search research articles
Contact Us
Filters
Showing results (191-200 of 197) with videos related to
Page
of 20
Sort By:
You have reached the last page of results.
This site can display upto 197 results.
The American Journal of Medicine
|
October 1, 1995
Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia
P Raskin, O P Ganda, S Schwartz, et al.
Diabetes, Obesity & Metabolism
|
October 6, 2015
AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes
L Katz, N Manamley, W J Snyder, et al.
American Journal of Hypertension
|
April 3, 2001
Familial factors in the antihypertensive response to lisinopril
N K Hollenberg, D A Anzalone, B Falkner, et al.
The New England Journal of Medicine
|
August 9, 1979
Somatostatinoma syndrome. Biochemical, morphologic and clinical features
G J Krejs, L Orci, J M Conlon, et al.
American Journal of Hypertension
|
June 2, 1998
Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension
J L Pool, R M Guthrie, T W Littlejohn, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 25, 2007
Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI
V Fonseca, G L Bakris, D S H Bell, et al.
Diabetes, Obesity & Metabolism
|
March 30, 2007
beta-blocker use and diabetes symptom score: results from the GEMINI study
J B McGill, G L Bakris, V Fonseca, et al.
Page
of 20
Search research articles
Search
Showing results (191-200 of 197) with videos related to
Sort By:
Page
of 20
You have reached the last page of results.
This site can display upto 197 results.
The American Journal of Medicine
|
October 1, 1995
Efficacy and safety of pravastatin in the treatment of patients with type I or type II diabetes mellitus and hypercholesterolemia
P Raskin, O P Ganda, S Schwartz, et al.
Diabetes, Obesity & Metabolism
|
October 6, 2015
AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes
L Katz, N Manamley, W J Snyder, et al.
American Journal of Hypertension
|
April 3, 2001
Familial factors in the antihypertensive response to lisinopril
N K Hollenberg, D A Anzalone, B Falkner, et al.
The New England Journal of Medicine
|
August 9, 1979
Somatostatinoma syndrome. Biochemical, morphologic and clinical features
G J Krejs, L Orci, J M Conlon, et al.
American Journal of Hypertension
|
June 2, 1998
Dose-related antihypertensive effects of irbesartan in patients with mild-to-moderate hypertension
J L Pool, R M Guthrie, T W Littlejohn, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
April 25, 2007
Differential effect of beta-blocker therapy on insulin resistance as a function of insulin sensitizer use: results from GEMINI
V Fonseca, G L Bakris, D S H Bell, et al.
Diabetes, Obesity & Metabolism
|
March 30, 2007
beta-blocker use and diabetes symptom score: results from the GEMINI study
J B McGill, G L Bakris, V Fonseca, et al.
Page
of 20